Literature DB >> 14687712

Natural mechanisms protecting against cancer.

Marek Jakóbisiak1, Witold Lasek, Jakub Gołab.   

Abstract

Carcinogenesis is a multistage process. At each step of this process, there are natural mechanisms protecting against development of cancer. The majority of cancers in humans is induced by carcinogenic factors present in our environment including our food. However, some natural substances present in our diet or synthesized in our cells are able to block, trap or decompose reactive oxygen species (ROS) participating in carcinogenesis. Carcinogens can also be removed from our cells. If DNA damage occurs, it is repaired in most of the cases. Unrepaired DNA alterations can be fixed as mutations in proliferating cells only and mutations of very few strategic genes can induce tumor formation, the most relevant are those activating proto-oncogenes and inactivating tumor suppressor genes. A series of mutations and/or epigenetic changes is required to drive transformation of a normal cell into malignant tumor. The apparently unrestricted growth has to be accompanied by a mechanism preserving telomeres which otherwise shorten with succeeding cell divisions leading to growth arrest. Tumor can not develop beyond the size of 1-2mm in diameter without the induction of angiogenesis which is regulated by natural inhibitors. To invade the surrounding tissues epithelial tumor cells have to lose some adhesion molecules keeping them attached to each other and to produce enzymes able to dissolve the elements of the basement membrane. On the other hand, acquisition of other adhesion molecules enables interaction of circulating tumor cells with endothelial cells facilitating extravasation and metastasis. One of the last barriers protecting against cancer is the activity of the immune system. Both innate and adaptive immunity participates in anti-tumor effects including the activity of natural killer (NK) cells, natural killer T cells, macrophages, neutrophils and eosinophils, complement, various cytokines, specific antibodies, and specific T cytotoxic cells. Upon activation neutrophils and macrophages are able to kill tumor cells but they can also release ROS, angiogenic and immunosuppressive substances. Many cytokines belonging to different families display anti-tumor activity but their role in natural anti-tumor defense remains largely to be established.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14687712     DOI: 10.1016/j.imlet.2003.08.005

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  41 in total

1.  Kinase domain insert containing receptor promotor controlled suicide gene system kills human umbilical vein endothelial cells.

Authors:  Zong-Hai Huang; Wen-Yu Yang; Qi Cheng; Jing-Long Yu; Zhou Li; Zong-Yan Tong; Hui-Juan Song; Xiao-Yan Che
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

Review 2.  Roles of the innate immune system in mammary gland remodeling during involution.

Authors:  Kamran Atabai; Dean Sheppard; Zena Werb
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

3.  Polyinosinic-cytidylic acid as an adjuvant on natural killer- and dendritic cell-mediated antitumor activities.

Authors:  Yu-Kun Huang; Zhi Zheng; Fu Qiu
Journal:  Tumour Biol       Date:  2013-02-22

Review 4.  Physical activity and its mechanistic effects on prostate cancer.

Authors:  A Wekesa; M Harrison; R W Watson
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-03-24       Impact factor: 5.554

Review 5.  Physical Activity, Exercise and Breast Cancer - What Is the Evidence for Rehabilitation, Aftercare, and Survival? A Review.

Authors:  Petra Wirtz; Freerk T Baumann
Journal:  Breast Care (Basel)       Date:  2018-04-11       Impact factor: 2.860

Review 6.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405

Review 7.  Physical Activity in Breast Cancer Patients during Medical Treatment and in the Aftercare - a Review.

Authors:  Freerk T Baumann; Wilhelm Bloch; Anke Weissen; Marie Brockhaus; Julia Beulertz; Philipp Zimmer; Fiona Streckmann; Eva M Zopf
Journal:  Breast Care (Basel)       Date:  2013-10       Impact factor: 2.860

8.  Lymphopenia and its association with survival in patients with locally advanced cervical cancer.

Authors:  Emily S Wu; Titilope Oduyebo; Lauren P Cobb; Diana Cholakian; Xiangrong Kong; Amanda N Fader; Kimberly L Levinson; Edward J Tanner; Rebecca L Stone; Anna Piotrowski; Stuart Grossman; Kara Long Roche
Journal:  Gynecol Oncol       Date:  2015-11-11       Impact factor: 5.482

9.  Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells.

Authors:  Ewelina Szliszka; Zenon P Czuba; Bogdan Mazur; Lukasz Sedek; Andrzej Paradysz; Wojciech Krol
Journal:  Int J Mol Sci       Date:  2009-12-24       Impact factor: 5.923

10.  Immunoglobulin g from breast cancer patients regulates MCF-7 cells migration and MMP-9 activity by stimulating muscarinic acetylcholine receptors.

Authors:  Laura T Pelegrina; María Gabriela Lombardi; Gabriel L Fiszman; María E Azar; Carlos Cresta Morgado; María E Sales
Journal:  J Clin Immunol       Date:  2012-09-25       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.